Search hospitals > California > Walnut Creek
Epic Care Cyberknife Center
Claim this profileWalnut Creek, California 94597
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Tumors
Conducts research for Colorectal Cancer
Conducts research for Melanoma
68 reported clinical trials
2 medical researchers
Summary
Epic Care Cyberknife Center is a medical facility located in Walnut Creek, California. This center is recognized for care of Cancer, Breast Cancer, Tumors, Colorectal Cancer, Melanoma and other specialties. Epic Care Cyberknife Center is involved with conducting 68 clinical trials across 231 conditions. There are 2 research doctors associated with this hospital, such as Lisa Bailey and James H. Feusner.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
HER2 positive
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Lisa BaileyContra Costa Regional Medical Center5 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
53 reported clinical trials
121 drugs studied
James H. FeusnerEpic Care-Dublin7 years of reported clinical research
Studies Breast Cancer
Studies Cancer
13 reported clinical trials
27 drugs studied
Clinical Trials running at Epic Care Cyberknife Center
Breast Cancer
Non-Small Cell Lung Cancer
Cancer
Bladder Carcinoma
Lung Cancer
Renal Cell Carcinoma
Tumors
Bladder Cancer
Melanoma
Colorectal Cancer
Questionnaire Choice
for Cancer Data Quality
The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.
Recruiting1 award N/A11 criteria
Symptom Monitoring
for Young Women on Hormone Therapy
This phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay on their hormone therapy medicines. The patient education tool contains interactive weblinks which provide patients with education material about breast cancer and side effects of therapy. Symptom monitoring is a weblink via email or text message with questions asking about symptoms. Hormone therapy for breast cancer can cause side effects, and may cause some women to stop treatment early. Asking about symptoms more often may help women keep taking hormone therapy medicines.
Recruiting1 award N/A13 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Epic Care Cyberknife Center?
Epic Care Cyberknife Center is a medical facility located in Walnut Creek, California. This center is recognized for care of Cancer, Breast Cancer, Tumors, Colorectal Cancer, Melanoma and other specialties. Epic Care Cyberknife Center is involved with conducting 68 clinical trials across 231 conditions. There are 2 research doctors associated with this hospital, such as Lisa Bailey and James H. Feusner.